Literature DB >> 9632135

Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials.

Y Maru1, S Yamaguchi, M Shibuya.   

Abstract

A paradox of Flt-1, a tyrosine kinase receptor for vascular endothelial growth factor (VEGF), is that the ligand cannot activate the receptor to stimulate growth of cells that exogenously overexpress the receptor. In order to find Flt-1 kinase-dependent biological systems, we obtained for the first time activated forms of the Flt-1 kinase in a ligand-independent manner. Replacement of the ABL sequences in the human leukemia oncoprotein BCR-ABL with the cytoplasmic domain of Flt-1 (BCR-FLT) followed by a retroviral random mutagenesis scheme gave constitutively active artificial chimera BCR-FLTm with mutations within the Flt-1 sequence. Like BCR-ABL it could, but not the original BCR-FLT, transform Rat1 fibroblasts, abrogate cytokine dependence in Ba/F3 cells, and induce neurite-like structures in neuronal PC12 cells. Interestingly, Rat1 cells transformed by BCR-FLTm formed tube-like structures in basement membrane matrix. BCR-FLTm retroviruses may be a very useful tool to investigate an as yet uncovered functions of the Flt-1 kinase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632135     DOI: 10.1038/sj.onc.1201786

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  The roles of vascular endothelial growth factor in bone repair and regeneration.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Bone       Date:  2016-06-25       Impact factor: 4.398

Review 2.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

3.  A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1.

Authors:  Rosana D Meyer; Moosa Mohammadi; Nader Rahimi
Journal:  J Biol Chem       Date:  2005-11-14       Impact factor: 5.157

4.  Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy.

Authors:  Aki Okamoto; Yasuhiko Iwamoto; Yoshiro Maru
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

5.  Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

Authors:  B Bussolati; C Dunk; M Grohman; C D Kontos; J Mason; A Ahmed
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

6.  A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.

Authors:  H Gille; J Kowalski; L Yu; H Chen; M T Pisabarro; T Davis-Smyth; N Ferrara
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

7.  Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Authors:  Y Itoh; A Takamura; N Ito; Y Maru; H Sato; N Suenaga; T Aoki; M Seiki
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 8.  Vascular endothelial growth factor control mechanisms in skeletal growth and repair.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

9.  IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma.

Authors:  Arnaud Picard; Elisa Boscolo; Zia A Khan; Tatianna C Bartch; John B Mulliken; Marie Paule Vazquez; Joyce Bischoff
Journal:  Pediatr Res       Date:  2008-03       Impact factor: 3.756

Review 10.  VEGF targets the tumour cell.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.